Trio of drugs may help fight ‘triple negative’ breast cancer
December 11th, 2010 - 6:40 pm ICT by ANIWashington, Dec 11 (ANI): Scientists at Johns Hopkins Kimmel Cancer Center have tested a blend of three drugs that could treat so called triple negative breast cancer.
Women with such cancers lack all three hormone receptors - estrogen, progesterone and human epidermal growth factor 2 (HER2) and currently, treatments for triple negative breast cancers are limited to surgery, chemotherapy and radiation, which provide some improvements but overall poor prognoses.
In the new study, Johns Hopkins scientists began with a drug called Entinostat, which blocks an enzyme that unfolds DNA, providing regulatory molecules access to genes within and also reactivates a gene called retinoic acid receptor-beta (RAR-B).
Thereafter, they added a drug called All Trans Retinoic Acid (ATRA), related to Vitamin A, which binds a protein made by the reactivated RAR-B gene.
Together, the ATRA drug and RAR-B gene act as a brake on cancer cell growth. The scientists completed the drug cocktail with conventional chemotherapy using either low doses of doxorubicin or paclitaxel.
The scientists noted that using these drugs individually have some impact on the tumour but the combined impact tips the scale in favor of killing more cells.
Tests on laboratory-cultured cells showed that the triple combo therapy halted the growth of multiple triple negative breast cancer cell lines more effectively than any one of the treatments alone. (ANI)
- Carrots can help prevent breast cancer - Apr 06, 2011
- Evidence of unusual drug-resistant breast tumours found - Oct 09, 2010
- Compound to starve cancers of sugar-based building blocks found - Nov 19, 2010
- Drug could prevent debilitating bone disease in wounded soldiers, kids - Apr 04, 2011
- Simple fingertip test may identify breast cancer patients at CTS risk - Dec 11, 2010
- Mice study shows slight changes in 2 genes launches breast cancer development - May 13, 2010
- Painkillers Can Make The Cancer Cells Kill Themselves - Jun 21, 2010
- Pomegranate juice could be key to new cancer therapies - Dec 13, 2010
- Novel way to kill treatment-resistant breast cancer stem cells - Jan 05, 2010
- Drug counters bone-damaging effects of breast cancer medication - Oct 10, 2011
- Scientists bring cancer cells back under normal control - Jan 19, 2011
- Gene to sabotage breast cancer cells - Feb 28, 2011
- Vitamin A plays key role in the human body - Mar 18, 2011
- New way of treating lung cancer soon - Oct 11, 2011
- Red wine compound 'can give a boost to breast cancer treatment' - Feb 15, 2011
Tags: breast cancer, breast cancer women, breast cancers, cancer cell growth, conventional chemotherapy, cultured cells, doxorubicin, drug cocktail, epidermal growth factor, her2, hopkins scientists, hormone receptors, johns hopkins, kimmel cancer center, paclitaxel, progesterone, prognoses, receptor beta, regulatory molecules, tumour